MedTrace Logo

Basal Plasma Lithium Levels and Suicidal Events

NCT05409794 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 158

Last updated 2024-08-09

No results posted yet for this study

Summary

Suicidal behavior is a major public health issue and there are currently no specific treatments for it.

However, lithium, the reference treatment for bipolar disorder, have been shown to be effective in preventing suicidal risk.

Apart from drug treatments, lithium is present in our environment and its levels varies from one individual to another, depending, especially, on diet.

Knowing that patients with a mood disorder generally have a poor lifestyle and a less rich and varied diet than the general population, variations in basal lithium levels can be expected in these patients.

Conditions

Interventions

BIOLOGICAL

Blood sample

Blood sample for the determination of plasma lithium levels

Sponsors & Collaborators

  • University Hospital, Montpellier

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-12-09
Primary Completion
2026-01-09
Completion
2027-01-09

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05409794 on ClinicalTrials.gov